Some visit links earn us a commission.
Quick verdict
LifeMD is the better pick for most patients on overall scoring. Mature publicly-traded telehealth with rare direct-supply deals from both Novo Nordisk and Eli Lilly. Membership is $75 the first month then $149/mo ongoing. The Wegovy pill is $149/mo at starter doses and $299/mo at full doses. Steady-state total runs about $448/mo (starter months about $298, first month $224). Wegovy injection runs higher and Zepbound vials from $349. Insurance navigation included. Opt-in money-back guarantee: stay enrolled 12 months and lose at least 10% body weight, or you're eligible for a refund per posted terms.
That said, Medvi wins on specific dimensions. Medvi runs a compounded-semaglutide and tirzepatide model at flat monthly pricing, with no lock-in and rapid intake. Comparable to Henry Meds and Mochi on price; less established clinical depth than Form Health or Knownwell. Best fit for cash-pay patients who want predictable monthly cost with minimal friction.
Side-by-side
| Medvi | LifeMD | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $448/mo (+ med separate) |
| Monthly cost gap | Medvi is $119/mo cheaper than LifeMD | |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 2 days | 2 days |
| Consultation type | Asynchronous | Async |
| Affiliate network | Direct | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Medvi | LifeMD | |
|---|---|---|
| Pricing transparency | 8/10 | 8/10 |
| Cancellation terms | 8/10 | 7.5/10 |
| Onboarding experience | 7/10 | 8.5/10 |
| Medication options | 7/10 | 9/10 |
| Member reviews | 9/10 | 8.2/10 |
When to choose Medvi
Best for flat compounded with no lock-in
Cash-pay patients who want flat predictable compounded GLP-1 pricing with no lock-in and same-week onboarding. Strong fit if you've taken GLP-1 before and want a simple ongoing prescription channel.
Medvi wins on cancellation terms, member reviews and runs $119/mo cheaper than LifeMD at the entry tier ($179 vs $298). Over a year that's $1,428 you keep. The caveat: Insurance-pathway shoppers, patients with multiple comorbidities needing clinical depth or anyone wanting branded Wegovy or Zepbound through standard PA. Note also: Compounded GLP-1 carries 503A regulatory exposure; see compounded callout
When to choose LifeMD
Best for insurance plus lifestyle support
Mainstream patients who want insurance navigation plus the option to cash-pay for branded GLP-1 at near-NovoCare/LillyDirect rates without leaving the platform.
LifeMD wins on onboarding experience, medication options on the dimensional scoring. The caveat: Patients chasing the absolute cheapest compounded option or wanting a pure cash-only flat rate. Note also: Publicly traded NASDAQ:LFMD with formal pharmaceutical supply agreements
If cost is your main filter
Medvi is the cheaper monthly: $179 all-in vs $298 for LifeMD. That's $119 a month or $1,428a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $357 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Medvi (month-to-month) and LifeMD (month-to-month) sit at the same cancellation tier. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Medvi cheaper than LifeMD?
Can I switch from Medvi to LifeMD mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
